Literature DB >> 31843706

PAK3 mutations responsible for severe intellectual disability and callosal agenesis inhibit cell migration.

Kévin Duarte1, Solveig Heide2, Sandrine Poëa-Guyon3, Véronique Rousseau4, Christel Depienne5, Agnès Rastetter6, Caroline Nava7, Tania Attié-Bitach8, Ferechté Razavi9, Jelena Martinovic10, Marie Laure Moutard11, Jacqueline Cherfils12, Cyril Mignot13, Delphine Héron14, Jean-Vianney Barnier15.   

Abstract

Corpus callosum agenesis (CCA) is a brain malformation associated with a wide clinical spectrum including intellectual disability (ID) and an etiopathological complexity. We identified a novel missense G424R mutation in the X-linked p21-activated kinase 3 (PAK3) gene in a boy presenting with severe ID, microcephaly and CCA and his fetal sibling with CCA and severe hydrocephaly. PAK3 kinase is known to control synaptic plasticity and dendritic spine dynamics but its implication is less characterized in brain ontogenesis. In order to identify developmental functions of PAK3 impacted by mutations responsible for CCA, we compared the biochemical and biological effects of three PAK3 mutations localized in the catalytic domain. These mutations include two "severe" G424R and K389N variants (responsible for severe ID and CCA) and the "mild" A365E variant (responsible for nonsyndromic mild ID). Whereas they suppressed kinase activity, only the two severe variants displayed normal protein stability. Furthermore, they increased interactions between PAK3 and the guanine exchange factor αPIX/ARHGEF6, disturbed adhesion point dynamics and cell spreading, and severely impacted cell migration. Our findings highlight new molecular defects associated with mutations responsible for severe clinical phenotypes with developmental brain defects.
Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cell adhesion; Cell migration; Cell spreading; Corpus callosum agenesis (CCA); Intellectual disability; Kinase; Neurodevelopmental disorder; PAK3; αPIX/ARHGEF6

Mesh:

Substances:

Year:  2019        PMID: 31843706     DOI: 10.1016/j.nbd.2019.104709

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  7 in total

Review 1.  Group I PAKs in myelin formation and repair of the central nervous system: what, when, and how.

Authors:  Yan Wang; Fuzheng Guo
Journal:  Biol Rev Camb Philos Soc       Date:  2021-11-22

2.  Missense variants in DPYSL5 cause a neurodevelopmental disorder with corpus callosum agenesis and cerebellar abnormalities.

Authors:  Médéric Jeanne; Hélène Demory; Aubin Moutal; Marie-Laure Vuillaume; Sophie Blesson; Rose-Anne Thépault; Sylviane Marouillat; Judith Halewa; Saskia M Maas; M Mahdi Motazacker; Grazia M S Mancini; Marjon A van Slegtenhorst; Avgi Andreou; Helene Cox; Julie Vogt; Jason Laufman; Natella Kostandyan; Davit Babikyan; Miroslava Hancarova; Sarka Bendova; Zdenek Sedlacek; Kimberly A Aldinger; Elliott H Sherr; Emanuela Argilli; Eleina M England; Séverine Audebert-Bellanger; Dominique Bonneau; Estelle Colin; Anne-Sophie Denommé-Pichon; Brigitte Gilbert-Dussardier; Bertrand Isidor; Sébastien Küry; Sylvie Odent; Richard Redon; Rajesh Khanna; William B Dobyns; Stéphane Bézieau; Jérôme Honnorat; Bernhard Lohkamp; Annick Toutain; Frédéric Laumonnier
Journal:  Am J Hum Genet       Date:  2021-04-23       Impact factor: 11.043

3.  Genomic legacy of migration in endangered caribou.

Authors:  Maria Cavedon; Bridgett vonHoldt; Mark Hebblewhite; Troy Hegel; Elizabeth Heppenheimer; Dave Hervieux; Stefano Mariani; Helen Schwantje; Robin Steenweg; Jessica Theoret; Megan Watters; Marco Musiani
Journal:  PLoS Genet       Date:  2022-02-10       Impact factor: 5.917

4.  Clinical and Molecular Aspects of the Neurodevelopmental Disorder Associated with PAK3 Perturbation.

Authors:  Giulia Pascolini; Federica Gaudioso; Chiara Passarelli; Antonio Novelli; Niccolò Di Giosaffatte; Silvia Majore; Paola Grammatico
Journal:  J Mol Neurosci       Date:  2021-07-05       Impact factor: 3.444

Review 5.  Neuronal Cytoskeleton in Intellectual Disability: From Systems Biology and Modeling to Therapeutic Opportunities.

Authors:  Carla Liaci; Mattia Camera; Giovanni Caslini; Simona Rando; Salvatore Contino; Valentino Romano; Giorgio R Merlo
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

Review 6.  The p21-activated kinases in neural cytoskeletal remodeling and related neurological disorders.

Authors:  Kaifan Zhang; Yan Wang; Tianda Fan; Cheng Zeng; Zhong Sheng Sun
Journal:  Protein Cell       Date:  2020-12-11       Impact factor: 14.870

Review 7.  Pathophysiological Mechanisms in Neurodevelopmental Disorders Caused by Rac GTPases Dysregulation: What's behind Neuro-RACopathies.

Authors:  Marcello Scala; Masashi Nishikawa; Koh-Ichi Nagata; Pasquale Striano
Journal:  Cells       Date:  2021-12-02       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.